Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

0.6874
Delayed Data
As of Jan 19
 +0.0024 / +0.35%
Today’s Change
0.60
Today|||52-Week Range
4.95
-10.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization136.0K135.0K129.0K123.0K
 
 
 
 
 
 
Operating ExpensesGross Income-136.0K-135.0K-129.0K-123.0K
 
 
 
 
 
General Expenses6.7M6.5M6.8M6.2M
 
 
 
 
 
Research And Development3.9M3.4M3.2M2.9M
 
 
 
 
 
Total Operating Expenses6.8M6.7M6.9M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.8M-6.7M-6.9M-6.3M
 
 
 
 
 
Extraordinary Credit1.4M241.0K554.0K0.00
 
 
 
 
Extraordinary Charge0.000.000.00-3.1M
 
 
Interest Expense On Debt38.0K20.0K20.0K18.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.4M-6.4M-6.3M-9.4M
 
 
 
 
 
Net Income-5.4M-6.4M-6.3M-9.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.0M32.1M32.2M33.4M
 
 
 
 
 
Shares To Calculate EPS Diluted32.0M32.1M32.2M33.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.20-$0.20-$0.28
 
 
 
 
 
EPS Diluted-$0.17-$0.20-$0.20-$0.28